A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery

Open Label, Phase/3 Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02888210

Enrollment

110

Registered

2016-09-02

Start date

2016-09-03

Completion date

2017-11-22

Last updated

2018-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Brief summary

To evaluate safety and efficacy of MD-15 intraocular lens implanted into the aphakic eyes

Interventions

DEVICEMD-15 Intraocular Lens

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients who intend to undergo phacoemulsification cataract extraction

Exclusion criteria

* Patients who undergo secondary implantation * Patients with vision loss induced by causes other than cataract * Patients who the principal investigator/subinvestigator considers ineligible for enrollment

Design outcomes

Primary

Measure	Time frame
Corrected visual acuity	Week 52

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026